Skip to content

Opening book details…

About this Medicine article

Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: Rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial by Robert M. Califf; Mitradev Boolell; Steven M. Haffner; M. Angelyn Bethel; John McMurray; Anil Duggal; Rury R. Holman is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Robert M. Califf; Mitradev Boolell; Steven M. Haffner; M. Angelyn Bethel; John McMurray; Anil Duggal; Rury R. Holman
Publisher
Elsevier Science; Elsevier ; Mosby Inc.; Elsevier BV (ISSN 1097-6744)
Published
2008
Field
Medicine (Health Sciences)

More by Robert M. Califf; Mitradev Boolell; Steven M. Haffner; M. Angelyn Bethel; John McMurray; Anil Duggal; Rury R. Holman

Browse all works by Robert M. Califf; Mitradev Boolell; Steven M. Haffner; M. Angelyn Bethel; John McMurray; Anil Duggal; Rury R. Holman